Biocon Limited has informed the Exchange regarding a press release dated September 08, 2026, titled "Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil".
Biocon Limited Press Release Sep 08 2026
Earlier from Biocon
- Biocon Announces Supplemental U.S. FDA Approval For Prefilled Autoinjector For YESINTEK
- Biocon Launches Aflibercept Biosimilar In The United States
- Biocon Limited Press Release Aug 05 2026
- Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg